Cargando…

Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells

Breast cancer stem cells (BCSCs) play a critical role in chemoresistance, metastasis, and poor prognosis of breast cancer. BCSCs are mostly dormant, and therefore, activating them and modulating the cell cycle are important for successful therapy against BCSCs. The tumor microenvironment (TME) promo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skolastika, Skolastika, Hanif, Naufa, Ikawati, Muthi, Hermawan, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286982/ https://www.ncbi.nlm.nih.gov/pubmed/35845599 http://dx.doi.org/10.1155/2022/4172531

Ejemplares similares

Integrative Bioinformatics Study of Tangeretin Potential Targets for Preventing Metastatic Breast Cancer
por: Hermawan, Adam, et al.
Publicado: (2021)

Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study
por: Hermawan, Adam, et al.
Publicado: (2022)

Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen
por: Hermawan, Adam, et al.
Publicado: (2022)

Bioinformatics and In Vitro Studies Reveal the Importance of p53, PPARG and Notch Signaling Pathway in Inhibition of Breast Cancer Stem Cells by Hesperetin
por: Hermawan, Adam, et al.
Publicado: (2021)

Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies
por: Hermawan, Adam, et al.
Publicado: (2021)

Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen
por: Ibadurrahman, Wilfan, et al.
Publicado: (2022)

MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis
por: Azzahra, Salma Nur Azizah, et al.
Publicado: (2022)

Loss of HtrA1 serine protease induces synthetic modulation of aortic vascular smooth muscle cells
por: Ikawati, Muthi, et al.
Publicado: (2018)

IRF4 as an Oncogenic Master Transcription Factor
por: Wong, Regina Wan Ju, et al.
Publicado: (2022)

Honokiol inhibits the growth of SKBR3 cells
por: Shi, He, et al.
Publicado: (2020)

Cell Cycle Modulation of CHO-K1 Cells Under Genistein Treatment Correlates with Cells Senescence, Apoptosis and ROS Level but in a Dose-Dependent Manner
por: Jenie, Riris Istighfari, et al.
Publicado: (2019)

Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation
por: Meiyanto, Edy, et al.
Publicado: (2019)

Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy
por: Huang, Kao‐Jean, et al.
Publicado: (2018)

Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis
por: Subramaniam, Dharmalingam, et al.
Publicado: (2021)

Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia
por: Lim, Fang Qi, et al.
Publicado: (2022)

Honokiol blocks store operated calcium entry in CHO cells expressing the M3 muscarinic receptor: honokiol and muscarinic signaling
por: Wang, Hsiu-Jen, et al.
Publicado: (2013)

Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells
por: Arora, Sumit, et al.
Publicado: (2011)

Integrative Bioinformatics Analysis Reveals Potential Target Genes and TNFα Signaling Inhibition by Brazilin in Metastatic Breast Cancer Cells
por: Hermawan, Adam, et al.
Publicado: (2020)

Elimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme Cells
por: Lai, I-Chun, et al.
Publicado: (2015)

The Growth Suppression Activity of Diosmin and PGV-1 Co-Treatment on 4T1 Breast Cancer Targets Mitotic Regulatory Proteins
por: Musyayyadah, Hajidah, et al.
Publicado: (2021)

Pharmaceutical Evaluation of Honokiol and Magnolol on Apoptosis and Migration Inhibition in Human Bladder Cancer Cells
por: Wang, Hisao-Hsien, et al.
Publicado: (2020)

SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis
por: Chen, Xiaotian, et al.
Publicado: (2023)

Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells
por: CHANG, KEN-HU, et al.
Publicado: (2013)

Cytoprotective Properties of Citronella Oil (Cymbopogon nardus (L.) Rendl.) and Lemongrass Oil (Cymbopogon citratus (DC.) Stapf) through Attenuation of Senescent-Induced Chemotherapeutic Agent Doxorubicin on Vero and NIH-3T3 Cells
por: Salsabila, Dhiya Ulhaq, et al.
Publicado: (2023)

Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review
por: Raman, Rachna, et al.
Publicado: (2015)

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
por: Bonner, Michael Y., et al.
Publicado: (2016)

Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration
por: Yu, Chung-Ping, et al.
Publicado: (2021)

Antineoplastic Effects of Honokiol on Melanoma
por: Guillermo-Lagae, Ruth, et al.
Publicado: (2017)

The application prospects of honokiol in dermatology
por: Li, Yao, et al.
Publicado: (2022)

Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells
por: Maioli, Margherita, et al.
Publicado: (2018)

Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
por: Liu, Tingting, et al.
Publicado: (2020)

Liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization
por: Li, Shenglan, et al.
Publicado: (2021)

Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor
por: Singh, Tripti, et al.
Publicado: (2015)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
por: Salgado-Benvindo, Clarisse, et al.
Publicado: (2023)

Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin
por: Mikhaevich, Ekaterina I., et al.
Publicado: (2023)

Honokiol is a FOXM1 antagonist
por: Halasi, Marianna, et al.
Publicado: (2018)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Honokiol and Magnolol: Insights into Their Antidermatophytic Effects
por: Trifan, Adriana, et al.
Publicado: (2021)

Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells
por: Chen, Xi-rui, et al.
Publicado: (2011)

Honokiol and Alpha-Mangostin Inhibit Mayaro Virus Replication through Different Mechanisms
por: Valdés-Torres, Patricia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c022vmsskm8n0jk48n1849r8dh